Who we are


We are a team of dedicated biopharmaceutical professionals, each with decades of experience, all committed to making a difference in the lives of everyday people through the development of affordable, easy-to-use drug products addressing unmet medical needs.


We have developed a new platform technology designed to make it easy for anyone to administer urgently needed drugs, without training or prior experience, when patients are unable to treat themselves and time is of the essence.

Bruce Cohen

Chair and CEO

Bruce has been an entrepreneur

and senior manager in biotech for

more than 30 years, with 

experience at Baxter, Monitor 

Group, Sequus, Acacia, GeneSoft,

VitaPath and Iconic.  He's currently 

a venture partner with Xeraya 

Capital. Bruce has a BA and MA 

from Tufts and an MBA from

Harvard Business School..

Nicole McKnight, PhD

President and COO

Nicole is an experienced operator

and former cell biologist and

neuroscientist, with roles as

founding managing director of

BioLabs@NYULangone and CEO

of Stellate Therapeutics. She is

a graduate of UChicago, earned

her PhD at University College 

London and completed her

post-doc at Mount Sinai.

Edward Schnipper, MD

Chief Medical Officer

Ed brings more than 30 years of experience in biopharmaceuticals and clinical and regulatory affairs, with experience at Roche, Sequus, Alza, J&J and Velocity.  He completed his MD at Georgetown Medical and fellowships at NYU and Memorial Sloan Kettering. 

All rights reserved. Buckle Therapeutics Inc. © 2024

We need your consent to load the translations

We use a third-party service to translate the website content that may collect data about your activity. Please review the details in the privacy policy and accept the service to view the translations.